Correlation Between Pfizer and Autolus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pfizer and Autolus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Autolus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Autolus Therapeutics, you can compare the effects of market volatilities on Pfizer and Autolus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Autolus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Autolus Therapeutics.

Diversification Opportunities for Pfizer and Autolus Therapeutics

0.55

Correlation Coefficient

Pfizer  Autolus Therapeutics

Very weak diversification

The 3 months correlation between Pfizer and Autolus is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Autolus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Autolus Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Autolus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Autolus Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Autolus Therapeutics go up and down completely randomly.

Pair Corralation between Pfizer and Autolus Therapeutics

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Autolus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.4 times less risky than Autolus Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Autolus Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  285.00  in Autolus Therapeutics on July 21, 2024 and sell it today you would earn a total of  195.00  from holding Autolus Therapeutics or generate 68.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Autolus Therapeutics

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Autolus Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Autolus Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Autolus Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Autolus Therapeutics

The main advantage of trading using opposite Pfizer and Autolus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Autolus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Autolus Therapeutics will offset losses from the drop in Autolus Therapeutics' long position.

The idea behind Pfizer Inc and Autolus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.